Are the Mesothelial-to-Mesenchymal Transition, Sclerotic Peritonitis Syndromes, and Encapsulating Peritoneal Sclerosis Part of the Same Process?

<table>Evidence of MMT in EPS. Light microscopy analysis of a parietal peritoneal biopsy from a patient with EPS. Despite significant denudation of the peritoneal membrane, a submesothelial cytokeratin staining (brown) in submesothelial area is observed. This cytokeratin staining suggests the superficial precedence of these cells (arrows). Magnification ×200.</table>

International Journal of Nephrology

fig2

Figure 2

Figure 2: Are the Mesothelial-to-Mesenchymal Transition, Sclerotic Peritonitis Syndromes, and Encapsulating Peritoneal Sclerosis Part of the Same Process? 

Figure 2 | Are the Mesothelial-to-Mesenchymal Transition, Sclerotic Peritonitis Syndromes, and Encapsulating Peritoneal Sclerosis Part of the Same Process? 